Trademark search for:

THALIDOMIDE PHARMION

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results

Also check across:

USPTO Filing History

Key events recorded for this trademark application

2008-05-09 — Application filed
2008-05-13 — Application filed
2008-05-14 — Notice of design search code mailed
2008-08-26 — Final disposition recorded
2008-08-26 — Final disposition recorded
2008-08-26 — Assigned to examiner
2008-08-26 — Final disposition recorded
2008-08-27 — Office action issued
2008-09-05 — Assigned to lie
2008-09-16 — Teas/email correspondence entered
2008-09-16 — Correspondence received in law office
2008-09-22 — Suspension letter written
2008-09-22 — Letter of suspension e-mailed
2008-09-22 — Notification of letter of suspension e-mailed
2008-09-30 — Teas response to suspension inquiry received
2008-09-30 — Correspondence received in law office
2008-10-01 — Teas/email correspondence entered
2008-10-02 — Suspension letter written
2008-10-02 — Letter of suspension e-mailed
2008-10-02 — Notification of letter of suspension e-mailed
2008-10-22 — Teas response to suspension inquiry received
2008-10-22 — Teas/email correspondence entered
2008-10-22 — Correspondence received in law office
2008-10-24 — Approved for pub - principal register
2008-10-24 — Law office publication review completed
2008-11-12 — Notice of publication
2008-12-02 — Published for opposition
2009-01-12 — Teas post publication amendment received
2009-02-17 — Registered-principal register
2009-02-23 — Request to cancel inadvertently issued registration received
2009-03-10 — Assigned to paralegal
2009-03-16 — Assigned to petition staff
2009-04-14 — Reg. cancelled - restored to pendency
2009-05-19 — Attorney review/decision on amendment required
2009-05-21 — Data modification completed
2009-05-27 — Approved for pub - principal register
2009-05-27 — Law office publication review completed
2009-06-10 — Notice of publication
2009-06-30 — Published for opposition
2009-09-15 — Registered-principal register
2015-07-29 — Teas change of correspondence received
2016-04-22 — Cancelled sec. 8 (6-yr)
2016-04-22 — Final status recorded

Owner Information

Celgene Corporation
Summit , NJ

Filing Details

Filing Date:
2008-05-09

Status Date:
2016-04-22

Category:
Pharmaceuticals

Filing Year:
2008

THALIDOMIDE PHARMION

USPTO Filing History

Owner Information

Correspondent

Filing Details